Download Massachusetts Prevention Alliance The Marijuana Policy Initiative

Massachusetts Prevention Alliance
The Marijuana Policy Initiative
Section I.
Mobilizing and the Marijuana
Prevention Initiative in Massachusetts
February 2, 2012
What is the Massachusetts
Prevention Alliance?
Vision
The Massachusetts Prevention Alliance envisions
a day when the health and well-being of all
Massachusetts youth is central in all policies.
February 2, 2012
What is the Massachusetts
Prevention Alliance?
Mission
The Massachusetts Prevention Alliance is a
statewide organization that provides
educational resources and advocates for sound
public health and safety policies to protect and
promote the health and well-being of all
Massachusetts youth.
February 2, 2012
Nov:
Prop 2
Decriminalization
passes
May: Statewide
Conference Call on
Increased Marijuana
rates
Nov 2:
MA DPH’s
“Moving the
Commonwealth
to Action”
Conference
Nov:
Alcohol tax
is repealed
by MA
voters
2008
2010
Fall:
New MA DFC
Program Officer
Nov 4:
We make contact with Dr.
Kevin Sabet shortly after
he leaves White House
Nov 8:
Connect
with
Ohio
Action
Alliance
(Position
Paper)
Feb 2:
MAPA’s Debut
Nov 29:
DFC Action
Group meets in
Brockton
2011
Jan: Meeting with
Greg Grass at
CADCA Conference
plants seed for
mobilization effort
2012
Nov 3:
DFC Coalitions
meet w/ Greg
Grass in
Brockton
February
2, 2012
Nov 14:
Conference Call:
Sue Thau,
Michael Sparks
Dec:
MAPA Steering
Committee
Organizes &
Discusses
resources
needed
Two simultaneous efforts
I. MA Prevention Alliance. Create a coordinated,
collective force to influence policy in the interest of
youth health and safety, and raise awareness of the
effectiveness of prevention in all facets of reducing
youth substance use.
II. Address the immediate medicinal marijuana threat
to the Commonwealth. Educate residents on the
unintended and unforeseen consequences of MM
policy, including youth access, perception of risk, and
the bad precedent and health practice of
circumventing the FDA process for approval of
medicine.
February 2, 2012
Structure of the Massachusetts
Prevention Alliance
Steering
Committee
Advisory
Committee
Partners
Marijuana
Prevention
Initiative
Summit
Planning
Committee
Organizational
Development
Committee
Resource
Development
Committee
February 2, 2012
Communications
Committee
Outreach &
Membership
Committee
“ A group is working on advocacy efforts related to
marijuana policies in the state and how proposed
changes would affect youth prevention goals. I
applaud these efforts; because environmental
prevention strategies are at the heart of DFC goals,
you are encouraged to participate in and support
these efforts - where they align with your goals in
your action plans and logic models, and where the
data you collect shows youth marijuana use is
problematic.”
- Greg Grass, DFC Program Officer, SAMHSA, December 15, 2011
February 2, 2012
Funding The Initiative
• Anticipated program and project costs:
– Expert consultant/coordinator between now and
November
– Event planning
– Materials/messaging/web site/communication
costs
– Filing 501c3 & 501c4
• Coalitions (DFC) asked and allowed to set
aside $3K-$5K to cover the costs for this
effort.
February 2, 2012
Dr. Kevin Sabet, former Obama, Bush, Clinton
Advisor on drugs and consultant and
columnist on drug policies (New York Times,
Huffington Post, etc.). Dr. Sabet is an expert in
evidence-based drug prevention, treatment,
and law enforcement both domestically and
internationally. His specialty is in drug
legalization and “medical” marijuana.
February 2, 2012
Understanding the Difference
Between Lobbying v Advocacy
• Not asking anyone to “lobby” but rather
advocate for sensible policies that promote
DFC objectives.
• Lobbying is having a position on a specific
bill/piece of legislation and urging someone to
vote one way or another.
• If that situation comes up and we only have
fed dollars to work with, we will not expend
ANY fed dollars on it but rather volunteer our
time, which is permitted.
February 2, 2012
Understanding the Difference
Between Lobbying and Advocacy
• SAMHSA position
• CADCA position
• ONDCP position
February 2, 2012
What is our Initiative?
We want to protect the health and well-being
of all Massachusetts youth by educating
stakeholders (parents, law enforcement,
legislators, youth workers, voters, etc.) on the
threats of legalizing marijuana as a medicine
through the legislative process and/or ballot
measure.
February 2, 2012
Why do we care
about this?
February 2, 2012
Section 2.
Health Risks of Marijuana Use
February 2, 2012
Acute Effects of Marijuana –
During Intoxication (1)
•
•
•
•
•
•
•
Euphoria
Calmness
Appetite stimulation
Altered perception of time
Impairs coordination and balance
Acute psychosis; Panic (anxiety)
Increases heart rate: 20 - 100%
– Some evidence for increased risk of heart attack, may be exacerbated in
vulnerable individuals (e.g., baby boomers)
• Impaired Driving
– Increased risk of accidents
– Increased culpability
1. Hall W & Degenhard L (2009). Adverse health effects of non-medical cannabis use. Lancet, 374:1383-1391.
February 2, 2012
Acute Effects of Marijuana –
During Intoxication
• Cognitive Dysfunction (1)
– Impaired short-term memory
• Difficulty with complex tasks
• Difficulty learning
– Impaired decision-making
• Increased risky sexual behavior – HIV
• Increased Risk of Injuries (2)
– 30% higher according to one Kaiser study
– Increased risk of hospitalized injury from all causes: self-inflicted, motor
vehicle, assaults
– Individuals admitted into hospitals with marijuana abuse/dependence as
their primary diagnosis have median lengths of stay that are twice to
three times longer than those experienced by patients admitted for
alcohol, cocaine or heroin and therefore result in higher average charges
1. NIDA, Research Report Series: Cannabis Abuse, 2010 & Hall W & Degenhard L (2009). Adverse health effects of non-medical
cannabis use. Lancet, 374:1383-1391..
2. Polen, M.R; Sidney, S.; Tekawa, I.S.; Sadler. M.; and Friedman, G.D. Health care use by frequent marijuana smokers who do not
smoke tobacco. West J Med 158:596-601, 1993.
Pacula RL, Ringel J, Dobkins C, and K Truong, "The Incremental Health Services Cost Associated with Marijuana Use," Drug and
February 2, 2012
Alcohol Dependence, 92:248-257, 2008.
Emergency Department
Marijuana Mentions
In 2008, there were >370,000 ED visits with Marijuana mentions
140,000
Number of ER Visits
120,000
100,000
18 to 24
80,000
35 and older
60,000
25 to 34
12 to 17
40,000
20,000
0
2004
2005
2006
2007
Source: SAMHSA, Drug Abuse Warning Network, 2008.
February 2, 2012
2008
Long-Term Effects of Marijuana
•Cognitive Impairment (1)
– Deficits in learning, memory, attention, executive function
– Greater impulsivity, less cognitive flexibility
– Reversible with prolonged abstinence
•Negative Impact on Educational Outcomes (2)
– Greater drop out rates
– General dissatisfaction with life achievement, mental health, social
relationships
1. Solowij, N., et al. (2002). Cognitive functioning of long-term heavy cannabis users seeking treatment. Journal of the American
Medical Association, 287, 1123-1131. and Schweinsburg AD, Brown, SA, & Tapert, SF (2008). The influence of cannabis use on
neurocognitive functioning in adolescents. Current Drug Abuse Reviews, 1:99-111.
2. Macleod, J.; Oakes, R.; Copello, A.; Crome, I.; Egger, M.; Hickman, M.; Oppenkowski, T.; Stokes-Lampard, H.; and Davey Smith,
G. Psychological and social sequelae of cannabis and other illicit drug use by young people: A systematic review of longitudinal,
general population studies. Lancet 363(9421):1579-1588, 2004.
February 2, 2012
Long-Term Effects of Marijuana
• Brain Effects (1)
– Structural abnormalities have not been consistently identified.
– But chronic users show consistent alterations in brain activation of
higher cognitive networks.
– Emerging preliminary evidence suggests that heavy cannabis use
during adolescence may affect normal brain development.
• Respiratory system (2)
– Increases cough, phlegm production, and wheezing.
– Increased bronchitis, worsening of asthma symptoms or cystic fibrosis
symptoms
– No increase in emphysema
– Conflicting evidence for lung/upper airway cancer
1. Giedd. J. N. (2004). Structural magnetic resonance imaging of the adolescent brain. Annals of the NY Academy of
Sciences, 1021, 77-85. and Hall W & Degenhard L (2009). Adverse health effects of non-medical cannabis use.
Lancet, 374:1383-1391.
2. Tetrault, J.M., et al. Effects of cannabis smoking on pulmonary function and respiratory complications: a systematic
review. Arch Intern Med 167, 221-228 (2007).
Tashkin, DP (2005). Smoked cannabis as a cause of lung injury. Monaldi Archives for Chest Disease, 63(2):93-100.
NIDA, Research Report Series: Cannabis Abuse, 2010.
Hall W & Degenhard L (2009). Adverse health effects of non-medical cannabis use. Lancet, 374:1383-1391.
February 2, 2012
Long-Term Effects of Marijuana
• Mental illness
– Population studies have found evidence of an association between
cannabis use and increased risk of schizophrenia (and/or psychotic
symptoms), and to a lesser extent, depression, anxiety, and suicidal
behavior/ideation. (1)
1. McGrath, et al. (2010). Association between cannabis use and psychosis-related outcomes using sibling pair analysis in a cohort
of young adults. Archives of General Psychiatry, 67(5):440-447.
Room, R., Fischer, B., Hall, W., Lenton, S. and Reuter, P. (2010). Cannabis Policy: Moving Beyond Stalemate, Oxford, UK: Oxford
University Press.
Large, M., Sharma S, Compton M., Slade, T. & O., N. (2011). Cannabis use and earlier onset of psychosis: a systematic metaanalysis. Archives of General Psychiatry. 68. Also see Arseneault L, et al. (2002). Cannabis use in adolescence and risk for
adult psychosis: longitudinal prospective study. British Medical Journal. 325, 1212-1213.
February 2, 2012
Long Term Effects of Marijuana
Percent
Addiction: About 9% of users may become dependent, 1 in 6
who start use in adolescence, 25-50% of daily users
35
30
25
20
15
10
5
0
32
23
17
15
11
9
*
8
5
*
Estimated Prevalence of Dependence Among Users
Source: Wagner, F.A. & Anthony, J.C. From first drug use to drug dependence; developmental periods of risk for dependence upon
cannabis, cocaine, and alcohol. Neuropsychopharmacology 26, 479-488 (2002).
February 2, 2012
Dependence on or Abuse of
Specific Illicit Drugs in the Past Year
Among Persons 12 or Older, 2008
Sedatives
126
Inhalants
175
Heroin
282
Stimulants
351
Hallucinogens
358
Tranquilizers
451
Cocaine
1,411
Pain Relievers
1,716
Marijuana
4,199
0
500
1,000 1,500 2,000 2,500 3,000 3,500 4,000 4,500
Number in Thousands
Source: Substance Abuse and Mental Health Services Administration. (2009). Office of Applied Studies. Treatment Episode Data Set
(TEDS): 2009 Discharges from Substance Abuse Treatment Services, DASIS.
February 2, 2012
Increased Marijuana Treatment
Admissions 1993 and 2007
Percent of Admissions
60
1993
50
2007
40
30
20
10
0
Alcohol
Cocaine
Heroin
Source: Treatment Episode Data Set, US Health and Human Services, 1993 & 2007.
February 2, 2012
Marijuana
Treatment Admissions
by Drug, 2007
25
Percent
20
15
10
22.3
18
15.8
13.6
9.2
7.9
5
5
3.7
0.5
0
Source: Treatment Episode Data Set, US Health and Human Services, 1993 & 2007.
February 2, 2012
Potency: Increased THC Content in
Percent THC
Seized Marijuana, 1983-2009
10
9
8
7
6
5
4
3
2
1
0
Year
Source: The University of Mississippi Potency Monitoring Project
February 2, 2012
What Does Increased
Potency Mean?
• Potential for greater exposure, more adverse
health effects, higher rates of addiction
• ER visits involving marijuana have been going
up
Dependence rates increased between 19922002 in specific subgroups (1)
1.
Compton, W., Grant, B., Colliver, J., Glantz, M., Stinson, F. Prevalence of Cannabis Use Disorders in the United States: 19911992 and 2001-2002 Journal of the American Medical Association.. 291:2114-2121.
February 2, 2012
2009 Marijuana Use by High School
Students (MA and US)
Question
MA (%)
US (%)
Lifetime marijuana use
42.5
36.8
First marijuana use before age 13
9.0
7.5
Past 30-day use of marijuana
27.1
20.8
Past 30-day marijuana use on school property
5.9
4.6
Source: Centers for Disease Control and Prevention, Youth Online: High School YRBS.
February 2, 2012
Marijuana Use at the State and National Levels, 2010
Students in Grades 9-12
Source: CDC, Youth Online, High School YRBSS, http://apps.nccd.cdc.gov/youthonline/App/Default.aspx
February 2, 2012
Trends in Current Marijuana Use, Massachusetts (1993-2009)
Students in Grades 9-12
43%
2010
Source: CDC, Youth Online, High School YRBSS, http://apps.nccd.cdc.gov/youthonline/App/Default.aspx
February 2, 2012
Section 3.
State Policy Efforts to Legalize
Marijuana in Massachusetts
February 2, 2012
Decriminalization of Marijuana in
Massachusetts in 2008
• Ballot Initiative (Question 2) Passed in 2008
• Decriminalized possession of up to an ounce*
of marijuana for personal use
• Fine can be levied against person in possession
• Some communities passed local ordinances
prohibiting public consumption of marijuana
* Note: Depending on the quality, one ounce of
marijuana is equivalent to 60 to 120 joints
February 2, 2012
Effects of Decriminalization of
Marijuana in Massachusetts
• Has changed the way some view marijuana
(decreased perception of harm from use of
marijuana)
• Increased acceptance for marijuana use
• Has made marijuana more accessible to youth
• Has created enforcement of marijuana laws
more difficult for law officers
• Consequences offer little to no leverage for
getting youth treatment and/or support
February 2, 2012
Current Proposals
• Four main legislative bills for legalization of
marijuana
– One bill on full legalization (HB 1371)
– Two identical bills on medical marijuana (SB 1161
and HB 625)
– One other bill on medical marijuana (more
controlled, no distribution)
• Likely statewide ballot initiative (Nov 2012)
February 2, 2012
February 2, 2012
S. Bill 1161 and H. Bill 625
• Allow Mass DPH-certified individuals and
caregivers to cultivate marijuana for medical
purposes
• Medical conditions include: cancer, glaucoma,
HIV/AIDS, Hep C, ALS, Crohn's disease, PTSD,
or a chronic or debilitating disease or medical
condition, such as chronic pain, seizures,
nausea
February 2, 2012
S. Bill 1161 and H. Bill 625
• Allow Mass DPHdesignated medical
treatment centers/
dispensaries to acquire,
possess, cultivate,
manufacture, and
dispense marijuana and
supplies to registered
patients and caregivers
February 2, 2012
Statewide Ballot Initiative
• Patients diagnosed by a doctor certifying that
they have a debilitating medical condition
such as glaucoma, cancer or "other condition"
and that the use of marijuana to treat the
condition would outweigh the risks
• Patients cleared to buy up to a 60-day supply
of marijuana for their personal use from a
Mass DPH-certified nonprofit center that
would grow the plants
February 2, 2012
Statewide Ballot Initiative
• Legalization of medical marijuana is a step
towards legalization of marijuana by
marijuana proponents, a well-organized
movement
• Very organized and well-funded initiative
spearheaded by Massachusetts Patient
Advocacy Alliance and MassCANN (members
of NORML)
February 2, 2012
H. Bill 1371
• Creates the Cannabis Control Authority to
oversee the issuance of licenses for
cultivation, processing, trading, retail sales,
import, research and farmer-processorretailer licenses
• Modeled after Chapter 138 of the
Massachusetts General Laws, the Alcohol
Beverage Control Act
February 2, 2012
H. Bill 1371
• Establishes license fees of varying amounts
and excises taxes on cannabis sold at retail
• Allows those 21+ to cultivate cannabis for
their personal use and to give cannabis to
others 21+
February 2, 2012
Section 4.
Business of Marijuana Cultivation,
Possession, Use, and Distribution
February 2, 2012
Compassionate care or
big business?
$20k
Average $$/day profits per
dispensary
February 2, 2012
More dispensaries than Starbucks
Reported in The Daily July 5, 2011
Image from thcfinder.com
February 2, 2012
Compassionate care increased
access to marijuana?
< 5%
Only 10% of card holders are
cancer, HIV/AIDS, or glaucoma
patients
90% are registered for ailments
such as headaches and
athlete’s foot
February 2, 2012
Compassionate care or increased
access to marijuana?
>80%
Most card holders in CA and
CO are white men between the
ages of 17 and 35
No history of chronic illness
History of Alcohol and Drugs
Sources: O'Connell, T and Bou-Matar , C.B. (2007). Long term marijuana users seeking medical cannabis in California (2001–2007):
demographics, social characteristics, patterns of cannabis and other drug use of 4117 applicants. Harm Reduction
Journal, http://www.harmreductionjournal.com/content/4/1/16.
Nunberg, Helen; Kilmer, Beau; Pacula, Rosalie Liccardo; and Burgdorf, James R. (2011) “An Analysis of Applicants Presenting to a
Medical Marijuana Specialty Practice in California,” Journal of Drug Policy Analysis: Vol. 4: Iss. 1, Article 1. Available at:
http://www.bepress.com/jdpa/vol4/iss1/art1.
Colorado Department of Public Health and Environment, “Medical Marijuana Registry Program Update”, (July 31, 2011).
February 2, 2012
What could it mean to have a
medical marijuana dispensary or
“treatment center” in
Massachusetts?
February 2, 2012
What is the harm?
What does all this mean?
• Each card holder is entitled to possess 4-8
ounces of marijuana and up to 24-48 plants
depending on the bill
• 1 ounce of marijuana =
60-120 joints
February 2, 2012
What is the harm?
What does all this mean?
Allows Massachusetts Department of Public
Health (DPH) certified patients to possess
and/or cultivate marijuana for “medical”
purposes. Allows 4 ounces and 24 plants.
According to NORML, “an ounce of 'standard
pot' equals 60 joints...” 1 plant is about 1-5
lbs; 1000 joints/pound
240 joints or 24K-120K (potential) joints –
per person!
February 2, 2012
Is Marijuana Medicine?
• Whole plant is not medicine
• Some constituents, and their synthetics, are:
– Never smoked
– Dronabinol (Marinol ®) is synthetic THC delivered
by pill (Schedule III)
– Nabilone (Cesamet ®) mimics synthetic THC, also
delivered by pill (Schedule II)
• Other medications in development currently
– Today, over 100 DEA-licensed researchers to
research marijuana and its constituents
February 2, 2012
Bypassing the FDA Process
Before FDA approves a drug as medicine, testing is
done to:
 Determine the benefits and risks of the drug
 Determine how it may interact with other
drugs
 Assure standardization of the drug
 Determine the appropriate dosage levels
 Identify and monitor side effects
 Identify the safe means of administering the
drug
February 2, 2012
“Medical” Marijuana
The IOM Report (ONDCP commissioned in 1999)
• Constituents of the marijuana plant show
promise for treating pain, nausea, wasting
• It is justified to conduct research into marijuana’s
active ingredients for conditions or diseases such
as pain and nausea, as well as on non-smoked
delivery systems
• “..(t)here is little future in smoked marijuana as
a medically approved medication.”
February 2, 2012
Cannabinoid-based
FDA Approved Drugs
• Sativex is in the process of being studied
• Approved in Canada and throughout Europe
• Administered via an oral spray
Research on the efficacy of
cannabinioids is not
focused on raw/crude
marijuana, but in the
individual components that
may have medical use
February 2, 2012
Section 5.
Consequences of Legalizing
Marijuana
February 2, 2012
Consequences of Legalizing
Marijuana
• 8 out of 10 states with the highest percentage of
those aged 12-25 who used Marijuana in the past 30
days were in states that allowed the cultivation and
the sale of marijuana for “medicinal” purposes.
• Such states are also the majority of states in the top
ten for first time marijuana use rates.
• Decreases of perception of harm.
February 2, 2012
Changes in Attitude Lead to
Changes in Use
Marijuana Use and Perceived Risk among 12th Graders, 1975 to 2009
Past Year Use
Perceived Risk
60
50
Percent
40
30
20
10
0
75
78
81
84
87
90
93
Year
Source: The Monitoring the Future study, the University of Michigan
February 2, 2012
96
99
02
05
08
Consequences of Legalizing
Marijuana
•The younger youth begin to use marijuana, the
more likely they are to be addicted to
marijuana or other substances later in life.
•Increased crime in states with “medicinal”
marijuana laws, especially in states with
dispensaries.
• Increases in drugged driving rates.
February 2, 2012
Section 6.
Action Steps
February 2, 2012
Action Steps Needed
1: Fund efforts to address this threat
2: Follow Legislation and Other Efforts to
Change Environment on Marijuana Use
3: Consolidate and Educate Fellow Prevention
Community On Marijuana Issues
4: Proactively Support Ideas That Will Gain
Widespread Support
5: Create Infrastructure to Educate in the
Future on Similar Issues
February 2, 2012
1. Fund The Effort
• Peter Lewis, Founder of Progressive Insurance
–$525,000 (over 95%)
–Money going to:
• Polling
• Signature Collection
• Public Relations and
Communications Strategies
February 2, 2012
1. Fund The Effort
• We need funds for:
– Expert consultant/coordinator between now and
November (min. $30,000, max. $50,000)
• Guidance through all action steps.
• Onsite training (through summits and conferences).
• Education materials regarding the impact of marijuana
on adolescent development and access, document
preparation and creation of outreach documents. (Opeds, LTEs, etc).
• On-call for emergency documents related to marijuana
that require rapid turnaround.
February 2, 2012
1. Fund The Effort
• We need funds for:
– Event planning (approx. $13,000)
– Materials/messaging/web site/communication
costs (approx. $10,000)
– Filing 501c3 & 501c4 (approx. $4,000)
February 2, 2012
2. Follow Efforts
• Extremely well organized and well funded
legalization advocates in our state
– Massachusetts Patient Advocacy Alliance
– Massachusetts Cannabis Reform Coalition: The
Massachusetts chapter of NORML
February 2, 2012
2. Follow Efforts
• Four Main Legislative Bills
– Two identical bills on medical marijuana
– A more modest bill on medical marijuana
– One on full legalization
• Statewide Ballot Initiative?
February 2, 2012
3. Consolidate and Educate Fellow
Prevention Community On Marijuana
• Organize Summit
• Organize our allies in one place before major
threats progress
• Train them up on media/PR issues, lobbying
issues, talking points
• Provide support and structure, form
committees and give homework to local folks
so they can get our message out
February 2, 2012
What Would a Summit NOT Do?
• Go exhaustively over research findings
• Convince people that marijuana is not a good
thing
• Be open to the press
February 2, 2012
Possible Summit Agenda
Why We Are Here
What We Have Learned – Both in MA and other
states
Panel Discussion on Issues in Different Area of the
State
Talking Points
Grasstops Organizing
Lobbying Rules
Town Hall Discussion
February 2, 2012
Activities at the Summit
• Regional and Sector Workgroups with Specific
work plans
• Form Committees for Action
February 2, 2012
Activities at the Summit
Sector Workgroups will:
• List key partners (current or future) in your
sector (be specific about group names)
• List key opponents in your sector
• List some strengths and weaknesses of our
engagement with this sector (e.g. we have
community roots with these groups or we
don’t have many contacts in this sector, etc.)
February 2, 2012
Activities at the Summit
• List specific ways we can seek out new allies in
our sector
• What will your core messages be to these
groups?
• How will you overcome challenges in the
messaging to your sector (e.g. if your sector
thinks that marijuana is harmless, how will
this be overcome?)
February 2, 2012
Activities at the Summit
• How will you engage the media on this issue
from your sector’s perspective? (Be as specific
as possible – e.g. name specific news outlets
in your areas and how you will target)
• List Milestones Your Group will Achieve
February 2, 2012
Committees
Topic
Goal
Committee Tasks
Committee Membership
- Chair
- Members
February 2, 2012
Objectives/Milestones
Deliverable
- description
Champions
Due Date
Check Box
February 2, 2012
Conference (closer to date of major
legislation/action)
• Once key dates are identified (general
referenda vote, etc.)
• Invite public officials and the media
• Major press conference with key leaders
February 2, 2012
5. Proactively Support Ideas That Will Gain
Widespread Support
• Sensible policies that legislators and others
can rally around
– E.g. The idea of speeding up research into
nonsmoked marijuana components and
encouraging research protocols as recommended
by the 1999 IOM report on marijuana as medicine
February 2, 2012
4. Create Infrastructure to Educate in the
Future on Similar Issues
• The model we create can work for future
campaigns, on marijuana and other issues
that may arise.
February 2, 2012
Where Do We Go From Here?
• Obtain resources to support the efforts and
the organizational structure
• Prepare for mid-April Summit
• Meet lawmakers and tell them what we are
about, and get known among lawmakers
• Keep track of legislative and other
developments
February 2, 2012
Immediate Step #1
• Sign up to be a member of a committee!
– Organization Development Committee: Set up 501c3 w/
leadership.
– Summit Committee: Plan event with all details.
– Resource Development Committee: Secure funding for
this state-wide initiative. Identify potential funders,
make contact and generate funding support.
– Outreach and membership Committee: Build
participation at Summit and in MAPA.
– Communications Committee: Internal and external
resource portal. Tools and website.
February 2, 2012
Immediate Step #2
• Help us fund the initiative!
– Contribute coalition grant funds
– Donate personally
– Join our fundraising efforts
February 2, 2012
Organizational Development Committee
•
•
•
•
Chair: Tami Gouveia
Membership: 3-4 people
Time commitment: 2-4 hours per month
Develop a 1 and 2 year strategic action plan to
develop the organization
• Support the Steering Committee in determining
incorporation options
• Develop materials and tools to support the
development of MAPA
• Reports to the Steering Committee
February 2, 2012
Organizational Development Timeline
Planning MAPA
Feb. 2012
Phase 1:
Agree on
Vision &
Mission
Building MAPA
Mar. 2012
Apr. 2012
Phase 2:
Develop
Business Plan &
Documents for
Incorporation
Phase 3:
File 501 © 3
Phase 4:
Implement Plan
Develop Action
Plan with
Benchmarks
Monitor Progress
February 2, 2012
May 2012
Summit Planning Committee
•
•
•
•
•
Chair: Kirsten Doherty
Membership: 4-5 people
Timeframe: Now – April 2012
Time commitment: 6-8 hours per month
Reports to the Steering Committee
February 2, 2012
Summit Planning Committee
Goal:
Implement a state-wide Summit for 150-200 people
to build a base of members, donors and advocates
to support the MA Prevention Alliance and its
advocacy efforts.
How:
– Planning day
– Marketing
– Logistics
February 2, 2012
Resource Development Committee
• Leadership: volunteer Co-chairs
• Membership: 7-10 people representing MA
regions (boundaries to be defined)
• Timeframe: Now – December 2012
• Time commitment: 6-8 hours per month
• Reports to Steering Committee
February 2, 2012
Resource Development Committee
Goal:
Raise money and in-kind donations by December 2012
from individuals and entities across Massachusetts to
support MAPA and advocacy efforts.
How:
– Research and identify potential funders
– Solicit gifts from individuals, businesses,
foundations, etc.
– Create infrastructure for raising and tracking funds
February 2, 2012
Outreach & Membership Committee
• Chair: Dave Shavel
• Membership: 5-7 people
• Identify specific individual and organizations to
engage
• Determine the most appropriate way to engage
and educate
• Work with other committees to develop
outreach and education materials
• Develop recruiting and member orientation
materials and coordinate recruiting efforts
• Follow up and orient new members
• Reports to Steering Committee
February 2, 2012
Outreach and Membership Timeline
Jan. 2012
Apr. 2012
Kick-off
Summit
Phase 1:
Recruit
Allies
Aug. 2012
Campaign Kick-off
Phase 2:
Build
Partnerships
Phase 3:
Public
Advocacy
Nov. 2012
Election
Phase 4:
Celebrate &
Follow Up
Recruit Allies: Identify key individuals and organizations who support the
campaign. Clarify potential roles and invite to the Summit in April.
Build Partnerships: Expand outreach to individuals and organizations that
can organize and recruit local and statewide supporters and advocates.
Provide information and training to the individuals and organizations.
Public Advocacy: Public awareness campaign to educate the public and “get
out the vote” campaign.
Celebrate and Follow Up: Celebrate the victory and follow Up as needed.
February 2, 2012
Communications Committee
•
•
•
•
•
•
•
Chair: Carol Read
Membership: 3-4 people
Develop website layout and content
Compile and distribute educational resources
Develop talking points and MAPA materials
Track media outlets and networks
Develop system for regular communications
with partners
• Reports to Steering Committee
February 2, 2012
Committee Chairs
• Organizational Development Committee
– Tami Gouveia, [email protected]
• Summit Planning Committee
– Kirsten Doherty, [email protected]
• Resource Development Committee
– [email protected]
• Outreach and Membership Committee
– Dave Shavel, [email protected]
• Communications Committee
– Carol Read, [email protected]
February 2, 2012